We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

16 hedge funds and large institutions have $482K invested in Arcadia Biosciences in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

523% more capital invested

Capital invested by funds: $77.4K → $482K (+$405K)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

23% more funds holding

Funds holding: 13 → 16 (+3)

14.14% more ownership

Funds ownership: 2.85% → 16.99% (+14%)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$312K
2
SM
Sabby Management
Florida
+$224K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$41.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$24.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.83K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$148
2
Bank of America
Bank of America
North Carolina
-$24
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$220K +$312K +159,390 New
SM
2
Sabby Management
Florida
$158K +$224K +114,554 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$43.8K +$41.3K +21,088 +198%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$17.4K +$24.7K +12,614 New
State Street
5
State Street
Massachusetts
$16.8K – – –
VCM
6
Vanguard Capital Management
Pennsylvania
$13.3K +$18.9K +9,644 New
VFT
7
Vanguard Fiduciary Trust
Pennsylvania
$6.06K +$8.61K +4,394 New
TRCT
8
Tower Research Capital (TRC)
New York
$5.44K +$4.83K +2,464 +167%
UBS Group
9
UBS Group
Switzerland
$1.11K +$474 +242 +43%
SS
10
SBI Securities
Japan
$166 – – –
Group One Trading
11
Group One Trading
Illinois
$25 – – –
AssetMark Inc
12
AssetMark Inc
California
$7 – – –
Morgan Stanley
13
Morgan Stanley
New York
$3 – – –
SMBT
14
Southern Michigan Bank & Trust
Michigan
$3 +$4 +2 New
Citigroup
15
Citigroup
New York
$1 – – –
HI
16
Harbour Investments
Wisconsin
$1 – – –
Osaic Holdings
17
Osaic Holdings
Arizona
– -$148 -75 Closed
Bank of America
18
Bank of America
North Carolina
– -$24 -12 Closed

RKDA Hedge Fund Activity: Q1 2026 in Review

16 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2026, worth a combined $482K — up 523% from $77.4K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RKDA positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $312K. The largest seller was Osaic Holdings, exiting entirely with an estimated $148 sold.

  • 16 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2026, up from 13 in Q4 2025.
  • Funds reported $482K of Arcadia Biosciences stock for Q1 2026, up 523% quarter-over-quarter.
  • 6 funds opened new Arcadia Biosciences positions in Q1 2026 and 2 closed out, a net change of +4 holders.
  • The largest Arcadia Biosciences buyer in Q1 2026 was Armistice Capital, an estimated $312K added.
  • The largest Arcadia Biosciences seller in Q1 2026 was Osaic Holdings, an estimated $148 sold.

Based on aggregated 13F filings for Q1 2026.